¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ¼­¿ï ¼­¿ï´ëº´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) 1F ¼­¼ºÈ¯¿¬±¸È¦

±³À°ÁÖÁ¦ : Neurology of eye movements

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾȽŰæÀÇÇÐȸ

´ã´çÀÚ : ±èÀ¯Áø
¿¬¶ôó : 02-974-8606

À̸ÞÀÏ : ksno2012@gmail.com

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í »çÀüµî·Ïºñ: Àü¹®ÀÇ 30,000, ´çÀϵî·Ïºñ: Àü¹®ÀÇ 40,000 / Àü°øÀÇ ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:05~09:25 Transient monocular & binocular blindness ÀÌÁÖ¿µ(°¡Å縯ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:25~09:45 Ptosis (myogenic, N-M junction, neurogenic) ±ÇÀºÁø(Ãæ³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:45~10:05 Paralytic vs non-paralytic strabismus À±¼Ò¿¬(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:05~10:25 Anisocoria  °­ÁøÁÖ(ÀüºÏÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:25~10:35 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:35~10:50 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:50~11:15 Understanding of eye movement and objective measurement ÀÓÇÑ¿õ(ÇѾçÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:15~11:40 Eye movement recording using virtual reality and deep-learning model È«¼º±¤(ÇѸ²ÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:40~12:00 Saccadic analysis: update  ÃÖ¼­¿µ(ºÎ»êÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:00~12:10 Q & A -(-)

½Ä»ç 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:10~13:10 ÃÑȸ ¹× Lunch -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:10~13:35 Afferent visual symptoms and traumatic optic neuropathy  ½ÅÇöÁø(°Ç±¹ÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:35~13:55 Efferent visual symptoms and eye movement abnormalities    ÀÌÀͼº(¼øõÇâÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:55~14:15 Post-traumatic dizziness Á¤ÀϾï(°Ç±¹ÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:15~14:25 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:25~14:40 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:40~14:55 (±¸¿¬¹ßÇ¥)ANCA-associated pachymeningitis and bilateral optic neuropathy treated with steroid pulse therapy        ±èÈ«³²(¾ÆÁÖÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:55~15:10 (±¸¿¬¹ßÇ¥)Clinical Characteristics and Genetic Analysis of Chronic Progressive External Ophthalmoplegia À̼÷¹Î(ºÎ»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:10~15:25 (±¸¿¬¹ßÇ¥)Neuro-ophthalmologic and neuro-otologic findings in spinocerebellar ataxia type 7 ±èÀç¸í(Àü³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:25~15:40 (±¸¿¬¹ßÇ¥)Hypertensive optic neuropathy    ¹ÚÁöÀ±(¿ï»êÀÇ´ë ½Å°æ°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18
´ÙÀ½±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
302 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦25Â÷ ¼­¿ï½ÉÆ÷Áö¿ò : 2018-08-19 0 548 2018-08-08
301 ¼­¿ï Á¦4ȸ ´ëÇѽŰæ¿Ü°úº´¿øÇùÀÇȸ Çмú´ëȸ : 2018-08-19 0 1,276 2018-08-08
300 ¼­¿ï ´ëÇѳëÀκ´ÇÐȸ Á¦ 38Â÷ ÀÎÁ¤ÀÇ ¿¬¼ö°­Á : 2018-08-19 0 772 2018-08-08
299 ¼­¿ï 2018 ÀÇ·áÄ¿¹Â´ÏÄÉÀÌ¼Ç ±³À°Àü·« ¿öÅ©¼ó : 2018-08-18 0 541 2018-08-08
298 °æ±â ´ëÇÑôÃßÁ¾¾ç¿¬±¸È¸ Á¦18Â÷ Çмú´ëȸ : 2018-08-18 0 1,034 2018-08-08
297 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ iTHA (Innovation & Technology in Hip Athroplasty) : 2018-08-18 0 1,209 2018-08-08
296 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-18 0 612 2018-08-08
295 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 Kyung Hee Neurosurgery Symposium (ÀÓ¿µÁø ±³¼ö´Ô Á¤³â±â³ä ½ÉÆ÷Áö¿ò) : 2018-08-18 0 1,541 2018-08-08
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 637 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,094 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 926 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 564 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,163 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 881 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,258 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷